Skip to content

Transfusion Requirements in Cardiac Surgery III

An International, Multi-centre, Randomized Controlled Trial to Assess Transfusion Thresholds in Patients Undergoing Cardiac Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02042898
Acronym
TRICS-III
Enrollment
5028
Registered
2014-01-23
Start date
2014-01-20
Completion date
2017-10-01
Last updated
2018-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorder; Heart, Functional, Postoperative, Cardiac Surgery

Keywords

Cardiac Surgery, Transfusion

Brief summary

TRICS-III is an international, multi-centre, open-label randomized controlled trial of two commonly used transfusion strategies in high risk patients having cardiac surgery using a non-inferiority trial design.

Interventions

Sponsors

Unity Health Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 or older * Planned cardiac surgery using cardiopulmonary bypass * Informed consent obtained * Preoperative European System for Cardiac Operative Risk Evaluation (EuroSCORE I) of 6 or more

Exclusion criteria

* Patients who are unable to receive or who refuse blood products * Patients who are involved in a preoperative autologous pre-donation program * Patients who are having a heart transplant or having surgery solely for an insertion of a ventricular assist device * Pregnancy or lactation (a negative pregnancy test must be obtained prior to randomization for women of childbearing potential.) * Patients who are unable to receive or who refuse blood products

Design outcomes

Primary

MeasureTime frameDescription
Composite score of any one of the following: (1) all-cause mortality; (2) myocardial infarction; (3) new renal failure requiring dialysis; or (4) new focal neurological deficitUp to hospital discharge or postoperative day 28 (whichever occurs first)Composite score of any one of the following events occurring during the index hospitalization (from the start of surgery until hospital discharge or postoperative day 28, whichever comes first): (1) all-cause mortality; (2) myocardial infarction; (3) new renal failure requiring dialysis; or (4) new focal neurological deficit

Secondary

MeasureTime frame
Incidence of in-hospital myocardial infarctionUp to hospital discharge or postoperative day 28 (whichever occurs first)
Incidence of in-hospital new renal failure requiring dialysisUp to hospital discharge or postoperative day 28 (whichever occurs first)
Incidence of in-hospital new focal neurological deficitUp to hospital discharge or postoperative day 28 (whichever occurs first)
Length of stay in the ICU and hospitalUp to hospital discharge or postoperative day 28 (whichever occurs first)
Prolonged low output state defined as the need for two or more inotropes for 24 hours or more, intra-aortic balloon pump postoperatively or ventricular assist deviceUp to hospital discharge or postoperative day 28 (whichever occurs first)
Duration of mechanical ventilationUp to hospital discharge or postoperative day 28 (whichever occurs first)
Incidence of infectionUp to hospital discharge or postoperative day 28 (whichever occurs first)
Acute kidney injury (defined by Kidney Disease Improving Global Outcomes criteria)Up to hospital discharge or postoperative day 28 (whichever occurs first)
Incidence of gut infarctionUp to hospital discharge or postoperative day 28 (whichever occurs first)
The proportion of patients transfused and the number of blood products and hemostatic products utilized (e.g. red cells, plasma, platelets, cryoprecipitate, factor VII) (index hospitalization)Up to hospital discharge or postoperative day 28 (whichever occurs first)
Incidence of in-hospital all-cause mortalityUp to hospital discharge or postoperative day 28 (whichever occurs first)
New onset dialysis (since incident surgery) status6 months
Stroke6 months
Coronary revascularization6 months
Myocardial infarction6 months
Health Care Utilization6 months
Renal function, based on changes in postoperative serum creatinineUp to hospital discharge or postoperative day 28 (whichever occurs first)
Incidence of SeizuresUp to hospital discharge or postoperative day 28 (whichever occurs first)
Incidence of EncephalopathyUp to hospital discharge or postoperative day 28 (whichever occurs first)
Incidence of DeliriumUp to hospital discharge or postoperative day 28 (whichever occurs first)
Death6 months

Countries

Australia, Brazil, Canada, China, Colombia, Denmark, Egypt, Germany, Greece, India, Israel, Malaysia, New Zealand, Romania, Singapore, South Africa, Spain, Switzerland, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026